05.10.2022 | pharmaceutical forum
From the plant to the medicinal product
Published in: MMW – advances in medicine | Special issue 5/2022
abstract
Since medical cannabis became prescribable in 2017, Aurora has offered a broad product portfolio for targeted, individually tailored cannabis therapies. According to the company, it has several production facilities in Canada and in Europe, e.g. B. in Odense, Denmark. There, medicinal cannabis is produced on an area of more than 9,200 m 2 with a maximum capacity of up to 10,000 kg per year.
